Dr. Mark E. Robson

Dr. Mark E. Robson, MD, is a board-certified medical oncologist specializing in the identification and management of individuals who have inherited an increased risk for cancer. He focuses on helping men and women with cancer incorporate genetic information into their treatment plans, and for those who are at elevated risk but have not yet received a diagnosis, he works to develop strategies aimed at either preventing the development of cancer or limiting its impact if it occurs. His clinical work reflects a deep commitment to translating hereditary cancer risk information into meaningful, personalized care for patients and families.

His research focuses on identifying the best ways to use genetic information to improve outcomes for those with or at risk for hereditary cancers of all types. Within his oncology practice, he concentrates heavily on the management of young women with breast cancer, with a particular emphasis on hereditary breast cancer. He participates in the development of new treatments, including PARP inhibitors, which may be especially beneficial for this group of patients.

Dr. Robson also maintains a dedicated practice coordinating screening for women with mutations in BRCA1 or BRCA2, reflecting his commitment to comprehensive, proactive care for those at heightened genetic risk. His integrated approach, spanning clinical genetics, oncology, and research, positions him as a leading voice in the field of hereditary cancer management. Through his clinical and investigative work, he continues to advance understanding of how genetic risk can be harnessed to improve outcomes across a broad spectrum of cancer types.